CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Human Study on Qualia Senolytic Featured in International Journal of Molecular Sciences, Showing Potential Aging Benefits

Data ReadoutpositiveQualia SenolyticPositive
AI Analysis

Summary

Qualia Senolytic shows potential aging benefits based on published human study research in International Journal of Molecular Sciences, demonstrating changes in senescence-associated proteins.

Clinical Trial Data

Outcome Details

Published research in International Journal of Molecular Sciences showing potential changes in key senescence-associated proteins from one course of Qualia Senolytic supplementation

Importance:4/10
Sentiment:
0.60
senolyticagingsenescent cellspublished researchhuman studysupplementation
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on July 9, 2026 3:00 PM

Read Original